| Metric | Value (₹ Cr) | vs Q4 FY25 |
|---|---|---|
| Revenue | 12.51 | 1.8% |
| Total Income | 12.65 | 1.6% |
| Expenditure | 11.17 | 0.3% |
| PBT | 1.48 | 19.2% |
| Net Profit | 1.34 | 25.8% |
| OPM | 43.87% | 3.07pp |
| NPM | 10.57% | 2.03pp |
| EPS | 0.74 | 7.3% |
Vivo Bio Tech Ltd Announces Q1 2025 Results with 13.7% Revenue Growth
12 Aug 2025 · 12 Aug 2025, 08:05 pm
Summary
Vivo Bio Tech Ltd has announced its Q1 2025 results with a 13.7% growth in revenue. The meeting was held on August 12, 2025, and the Board approved the un-audited standalone and consolidated financial results for the quarter ended June 30, 2025. The company's revenue from operations stands at 1,241.8, with a profit before tax and exceptional items of 151.6.
Key Highlights
- 1
13.7% growth in revenue in Q1 2025
- 2
Un-Audited Standalone & Consolidated Financial Results approved for the quarter ended June 30, 2025
- 3
Issued and Subscribed Share Capital of the Company stands increased to Rs. 21,33,32,210/- divided into 2,13,33,221 Equity Shares of Rs.10/- each
- 4
Profit Before Tax & Exceptional Items stands at 151.6
Management Comments
Ayinam pud Ayinampudi
This is for your information and records. Thanking You, Yours faithfully For Vivo Bio Tech Limited
Kalyan Ram Mangipudi
Vivo Bio Tech Limited 03rd Floor, Ilyas Mohammed Khan Estate, 8-2-672/5&6, Road No.1, Banjara Hills, Hyderabad-500034 E-mail:investors@vivobio.com CIN: L65993TG1987PLC007163
Informational and educational content only. Not investment advice.